November 20 marks World COPD Day 2024, a worldwide effort with three goals: raising awareness, sharing knowledge and discussing ways to lower disease burden, according to the Global Initiative for ...

Patients with COPD are at increased risk for infections, making avoidance and effective treatments key in management.

Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved standardization of care, ...

BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016, 32,558 patients started a new inhaled treatment in 2022, according to a presentation at the ...

The recent clinical study update from Regeneron Pharmaceuticals and Sanofi focuses on the investigation of Itepekimab, an anti-IL-33 monoclonal antibody, to understand its effects ...

"Chronic Obstructive Pulmonary Disease Market Insight, Epidemiology and Market Forecast - 2034"The chronic obstructive ...

The DPP1 inhibitor market is experiencing significant growth, driven by the recent BRINSUPRI approval for non-cystic fibrosis bronchiectasis. The DPP1 inhibitors market is further supported by the ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil ...

In recent statements to the Financial Times and The Sunday Times, GSK plc GSK Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion (£1.6 ...

Oscillometry offers a promising alternative to spirometry for diagnosing asthma and COPD in primary care, according to a ...

Chronic Obstructive Pulmonary Disease (COPD): A progressive lung disease marked by airflow limitation and chronic inflammation, often associated with multiple systemic complications.